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                                                                                Abstract
Functional overreaching has been linked to alterations in immunity and host pathogen defense, but 
little is known as to whether or not running and cycling evoke different responses. This study 
compared inflammation, muscle damage and soreness, and innate immune function responses to a 
3-day period of intensified exercise in trained long distance runners (N = 13, age 34.4 +/- 2.4 year) 
and cyclists (N = 22, age 36.6 +/- 1.7 year, P = 0.452). Upper respiratory tract infection (URTI) 
symptomatology was monitored for 12 weeks using the Wisconsin Upper Respiratory Symptom 
Survey (WURSS), and subjects from both athletic groups came to the lab during week five and 
exercised 2.5 h/day for 3 days in a row at 70% VO2max. Blood samples were collected before and 
after the 3-day period of exercise, with recovery samples collected 1-, 14-, and 38 h-post-exercise. 
Samples were analyzed for muscle damage [creatine kinase (CK), myoglobin (MYO)], inflammation 
(CRP, IL-6, IL-8, IL-10, MCP), and innate immunity [granulocyte and monocyte phagocytosis (GR-
PHAG and MO-PHAG) and oxidative burst activity (GR-OBA and MO-OBA)]. Runners compared 
to cyclists experienced significantly more muscle damage (CK 133% and MYO 404% higher post-3 
days exercise), inflammation (CRP 87%, IL-6 256%, IL 8 61%, IL-10 32%, MCP 29%), and delayed 
onset of muscle soreness (DOMS, 87%). The 3-day period of exercise caused significant downturns 
in GR-PHAG, MO-PHAG, GR-OBA, MO-OBA by 14- and 38 h-recovery, but the pattern of change 
did not differ between groups. No group differences were measured for 12-week URTI severity (18.3 
+/- 5.6 and 16.6 +/- 4.0, P = 0.803) and symptom scores (33.4 +/- 12.6 and 24.7 +/- 5.8, P = 0.477). 
These data indicate that a 3-day period of functional overreaching results in substantially more 
muscle damage and soreness, and systemic inflammation in runners compared to cyclists, but 
without group differences for 12-week URTI symptomatology and post-exercise decrements in 
innate immune function. 
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1. Introduction
Most athletes incorporate periodized t
ules, with phases of functional overreaching
fied training to enhance future performance
Single bouts of heavy exertion cause wides
physiologic and immune biomarkers, and include transient altera-
cause greater muscle damage (Proske and Allen, 2005). The general 
assumption is that exercise-induced muscle damage is related to 
alterations in innate immune function and systemic inflammation, 
but evidence is limited and inconsistent (Paulsen et al., 2012). 
Bruunsgaard et al. (1997) showed a relationship between elevated 
creatine kinase (CK) and IL-6 after 30 min of eccentric compared to 
concentric cycling. However, this has not been a consistent finding, 
with comparisons across studies difficult to make due to theraining in their sched-
 or short-term intensi-
 (Meeusen et al., 2013). 
pread perturbations in tions in innate immune function and elevations in stress hor-
mones, pro-and anti-inflammatory cytokines, and reactive 
oxygen species (Henson et al., 2008; Nieman, 2001, 2009; Suzuki 
et al., 2006). These data imply that periods of intensified exercise
training may cause a more serious downturn in immune function 
and increased incidence of upper respiratory tract infection (URTI), 
but few well-designed studies have been conducted to verify this 
hypothesis (Meeusen et al., 2013). Even less is known regarding 
physiologic and immune responses to functional overreaching in 
runners compared to cyclists.
Exercise modes incorporating significant eccentric (e.g., run-
ning) compared to concentric (e.g., cycling) muscle contractions 
incorporation of a wide variety of exercise challenges and inter-
individual variation (Paulsen et al., 2012; Peake et al., 2005a,b;
Sugama et al., 2012; Suzuki et al., 2006; Toft et al., 2002). At the
160-km Western States Endurance Run (WSER), a strong relation-
ship was found between CK, delayed onset of muscle soreness
(DOMS), and a spectrum of systemic inflammation markers includ-
ing C-reactive protein (CRP), IL-6, granulocyte colony stimulating
factor (GC-SF), IL-1 receptor antagonist (IL-1ra), monocyte chemo-
attractant-1 (MCP-1), IL-10, and IL-8 (Nieman, 2009; Nieman et al.,
2003, 2005, 2006, 2007). During the week following the WSER,
DOMS also showed modest positive correlations with many of
the cytokines changes experienced during the race (Nieman,
2009). Contrary to expectations, the oxidative stress experienced
by the WSER athletes was modest, with no significant correlations
to cytokine, CK, and CRP changes (Nieman, 2009; Quindry et al.,
2008). Multiple triggers of cytokine release during extreme exer-
cise include elevations in stress hormones and other internal and
external stress signals, and metabolic demands such as glycogen
deficiency (Muñoz-Cánoves et al., 2013; Pedersen, 2012; Welc
and Clanton, 2013).
In a randomized, crossover study of 10 triathletes, single 2.5-h
bouts of running and cycling (75% VO2max) resulted in similar in-
nate immune responses but higher plasma IL-6 concentrations fol-
lowing running (Henson et al., 1999; Nieman et al., 1998a,b). In the
current study, these data were extended by comparing muscle
damage, inflammation, and innate immune biomarkers in runners
and cyclists during a 3-day period of intensified training (2.5 h/
day), and URTI symptomatology during a 12-week period. We
hypothesized that runners compared to cyclists would experience
higher muscle damage and inflammation during the 3-day func-
tional overreaching period, with decreased innate immune func-
tion and higher overall URTI rates during 12-weeks of monitoring
symptoms.2. Methods
2.1. Subjects and baseline testing
Subject recruitment was conducted via mass advertising to run-
ning and cycling clubs in the Charlotte, NC, metropolitan area. Sub-
jects included healthy, non-smoking runners (N = 13) and cyclists
(N = 22) ages 19–45 years who regularly competed in race events
and were capable of exercising for 2.5 h/day at high intensity for
3 days in a row in the performance laboratory. All subjects signed
informed consent forms, and study procedures were approved by
the Institutional Review Board at Appalachian State University.
Subjects consented to train normally, maintain weight, and avoid
the use of all herbs and medications known to affect inflammation
and immune function for the duration of the study (in particular,
all non-steroidal anti-inflammatory drugs). Subjects also agreed
to avoid use of vitamin and mineral supplements above 100% the
U.S. Daily Value. Prior to the start of the study, runners and cyclists
were tested for VO2max using graded exercise tests (with treadmills
and cycle ergometers, respectively) with the Cosmed FitMate met-
abolic device (Rome, Italy). Body composition was measured with
the Bod Pod body composition analyzer (Life Measurement, Con-
cord, CA). Demographic and training histories were acquired with
questionnaires, and subjects recorded URTI symptoms and minutes
trained each day in a log book throughout the entire 12-week
study.2.2. Exercise sessions
Subjects trained normally during the 12-week URTI logging
period, and participated in a 3-day period of intensified exerciseduring week 5. A standardized meal consisting of Boost Plus (Nés-
tle Nutrition, Slorham Park, NJ) was ingested at 12:00 pm each of
the 3 days, with energy intake adjusted to 10 kcal/kg body weight.
Boost Plus is a nutritionally complete, high-energy oral supple-
ment with an energy density of 6.4 kJ/mL (1.52 kcal/mL) and 15%
of energy as protein, 35% as fat, and 50% as carbohydrate, and 24
vitamins and minerals. Subjects reported to the Human Perfor-
mance Laboratory at 2:30 pm and provided blood samples in a
rested, seated position. Beginning at 3:00 pm, subjects ran on
treadmills or cycled on their own bicycles on CompuTrainers for
2.5-h at approximately 70% VO2max. Water was given ad libitum
throughout the 2.5-h exercise bouts, with no other beverage or
food allowed. Heart rate, rating of perceived exertion (RPE), and
distance completed were recorded every 30 min during the bout,
with oxygen consumption and ventilation measured with the
Cosmed FitMate metabolic device after 1 h of exercise. Subjects re-
peated this schedule for the next 2 days, but without pre-exercise
blood draws. Blood samples were taken immediately following the
final exercise bout on the third day, and 14-h- and 38-h-post-
exercise (i.e., the following two mornings).2.3. Complete blood count, creatine kinase, myoglobin, C-reactive
protein, DOMS
Routine complete blood counts were performed by our clinical
hematology laboratory using a Coulter Ac.T™ 5Diff Hematology
Analyzer (Beckman Coulter, Inc., Miami, FL) and provided total leu-
kocyte counts, and hemoglobin and hematocrit for the determina-
tion of plasma volume change using the method of Dill and Costill
(1974). Creatine kinase (CK), myoglobin (MYO), and high-sensitiv-
ity C-reactive protein (CRP) were measured using an LX-20 clinical
analyzer (Beckman Coulter Electronics, Brea, CA). Delayed onset of
soreness (DOMS) was assessed using the 1–10 scale produced by
Smith et al. (1993).2.4. Plasma cytokines
Total plasma concentrations of four inflammatory cytokines
[monocyte chemoattractant protein 1 (MCP), IL-6, IL-8, and IL-10]
were determined using an electrochemiluminescence based so-
lid-phase sandwich immunoassay (Meso Scale Discovery, Gaithers-
burg, MD, USA). All samples and provided standards were analyzed
in duplicate, and the intra-assay CV ranged from 1.7% to 7.5% and
the inter-assay CV 2.4 to 9.6% for all cytokines measured. Pre-
and post-exercise samples for the cytokines were analyzed on
the same assay plate to decrease inter-kit assay variability.2.5. Granulocyte and monocyte phagocytosis (G-PHAG, M-PHAG),
oxidative burst activity (G-OBA, M-OBA)
G-PHAG, M-PHAG, G-OBA, and M-OBA were assayed as
previously described (Knab et al., 2013). Briefly, phagocytosis
was measured through the uptake of Fluorescein isothiocyanate
(FITC)-labeled Staphylococcus aureus bacteria and oxidative burst
was measured through the oxidation of non-fluorescent hydroethi-
dine (HE) to fluorescent ethidium bromide in cells stimulated with
unlabeled bacteria. Samples were processed on a Q-Prep™ Work-
station (Beckman Coulter, Inc.) and analysis was performed within
18-h of blood collection using a LSR Fortessa flow cytometer (BD
Biosciences, San Jose, CA). After gating on the granulocyte and
monocyte populations using forward scatter and side scatter
(FlowJo analysis software, Tree Star, Inc., Ashland, OR), the mean
fluorescence intensity (MFI; x-mean) and percent positive cells
for FITC (FL1) and oxidized HE (FL2) were determined.
2.6. Upper respiratory tract infection
The Wisconsin Upper Respiratory Symptom Survey (WURSS)
was used to assess URTI severity and symptomatology (Barrett
et al., 2009). The WURSS-21 (short version used in this study) in-
cludes 10 items assessing symptoms (running nose, plugged nose,
sneezing, sore throat, scratchy throat, cough, hoarseness, head con-
gestion, chest congestion, feeling tired), 9 items assessing func-
tional impairments (think clearly, sleep well, breathe easily,
walk-climb stairs-exercise, accomplish daily activities, work out-
side the home, work inside the home, interact with others, live
your personal life), and 1 item assessing global severity and global
change. Subjects filled in the one-page WURSS-21 at the end of
each day during the 12-week monitoring period. This 12-week per-
iod covered the transition from summer to fall (mid-August to
mid-November). From the responses recorded during the 84-day
study, an URTI severity score was calculated by summing the daily
URTI global severity score (0 = not sick, 1 = very mild URTI to
7 = severe). The URTI symptom score for the 84-day period was cal-
culated by summing all 10 symptom scores for each day’s entry
(0 = do not have this symptom, 1 = very mild to 7 = severe). In sim-
ilar fashion, the URTI function ability score for the 84-day period
was calculated by summing all 9 function scores for each day’s en-
try (0 = do not have this symptom, 1 = very mild to 7 = severe).2.7. Statistical procedures
Data are expressed as mean ± SE. Subject characteristics and
performance data in Table 1 and URTI data in Table 2 were con-
trasted between groups using independent Student’s t-tests. All
other data were analyzed using a 2 (group)  5 (time) repeated-
measures ANOVA, between-groups design. When Box’s M sug-
gested that the assumptions necessary for the univariate approach
were not tenable, the multivariate approach to repeated measures
ANOVA was used (Pillais trace). Changes from pre-exercise to each
of four other time points were compared between groups using
student’s t-tests (when interaction effects were significant), with
significance set after Bonferroni adjustment (0.05/4) at P 6 0.0125.3. Results
Subject characteristics and 3-day exercise performance mea-
sures are summarized in Table 1. Runners and cyclists were of sim-
ilar age, body composition, and aerobic capacity, with the runners
weighing significantly less than the cyclists. Heart rate, oxygenTable 1
Subject characteristics and 3-day performance measures in runners and cyclists (mean±SE
Variable, subject characteristics Runners (N = 13)
Age (yr) 34.4 ± 2.4
Height (m) 1.70 ± 0.02
Weight (kg) 64.5 ± 3.0
Body fat (%) 17.3 ± 1.9
VO2max (ml kg1 min1) 54.7 ± 2.2
Max heart rate (beats/min) 179 ± 2.9
12-wk train volume (min/wk) 425 ± 63.6
3-Day exercise performance measures (2.5 h/day)*
Heart rate
Beats/min 149 ± 3.6
% max heart rate 82.5 ± 1.4
VO2
ml.kg-1.min-1 39.0 ± 1.3
% VO2max 71.9 ± 2.3
Ventilation (L/min) 60.7 ± 3.5
Rating of perceived exertion 13.2 ± 0.2
* Data represent 3-day averages from the three 2.5 h bouts.consumption, and ventilation did not differ significantly between
runners and cyclists when comparing averaged data across the
three 2.5-h exercise bouts. The average training volume (minutes
per week) during the 12-week monitoring period did not differ be-
tween groups (Table 1).
The running group included seven males and six females, and
the cycling group included 17 males and five females. Male and fe-
male athletes (all subjects combined) did not differ in age
(36.4 ± 1.8 and 34.5 ± 2.1, P = 0.557, respectively), VO2max
(55.7 ± 1.5 and 51.1 ± 2.4 ml kg1 min1, P = 0.105), or the percent-
age of VO2max maintained during the 3-day exercise period
(69.4 ± 1.6% and 70.6 ± 2.6%, P = 0.701). Additionally, a 2 (run, cy-
cle)  2 (male, female)  5 (time) repeated measures ANOVA re-
vealed no significant gender effects on all outcome measures
shown in Table 2 and Fig. 1 through 3. Thus data comparing run-
ners and cyclists in this paper are presented with male and female
athletes combined.
Plasma volume shifts at the end of the third day of exercise did
not differ between runners and cyclists (1.0 ± 0.5% and
0.8 ± 0.3%, P = 0.723). The 3-day exercise period caused signifi-
cant increases in CRP, IL-6, IL-8, IL-10, and MCP (time effects, all
P < 0.005) (Fig. 1A through 1E). Runners compared to cyclists expe-
rienced greater post-3-day-exercise increases in CRP (interaction
effect, P = 0.009), IL-6 (P = 0.001), IL-8 (<0.001), IL-10 (P = 0.045),
and MCP (P < 0.001). The higher CRP levels in the runners were evi-
dent at 38-h post-exercise (Fig. 1A), with no group differences in
cytokines measured at 14-h- and 38-h-post-exercise (Fig. 1B
through 1E). Runners also experienced greater post-3-day-exercise
increases in MYO (interaction effect, P = 0.001) and CK (P < 0.001)
compared to the cyclists (Fig. 2A and B). DOMS ratings were higher
in the runners compared to the cyclists immediately- and 1-h-
post-3-day exercise, with no differences 14-h- and 38-h-post-exer-
cise (interaction effect, P < 0.001) (Fig. 3).
Granulocyte and monocyte phagocytosis increased to a similar
degree following the 3-day exercise period in both runners and cy-
clists, and then decreased below pre-exercise levels at 14-h-post-
exercise (27% and 28%, respectively; time effect, P < 0.001 for both;
interactions effects P = 0.942 and P = 0.897, respectively) (Table 2).
Granulocyte and monocyte oxidative burst activity also increased
in similar fashion following the 3-day exercise period in both run-
ners and cyclists, and then decreased below pre-exercise levels
through 38-h-post-exercise (12% and 21%, respectively; time ef-
fect, P < 0.001 for both; interactions effects P = 0.871 and
P = 0.265, respectively) (Table 2). Total blood leukocyte counts in-
creased in both runners and cyclists, with no group differences in
the pattern of change over time (interaction effect, P = 0.176) (data).
Cyclists (N = 22) P-value
36.6 ± 1.7 0.452
1.75 ± 0.02 0.090
72.6 ± 2.39 0.045
18.8 ± 1.2 0.492
54.1 ± 1.6 0.811
180 ± 1.9 0.944
396 ± 41.8 0.567
143 ± 2.7 0.282
79.5 ± 1.1 0.118
36.5 ± 1.2 0.186
68.5 ± 1.6 0.217
68.5 ± 3.1 0.111
12.5 ± 0.3 0.084
Table 2
Granulocyte and monocyte phagocytosis and oxidative burst activity (mean ± SE).
Variable Runners (N = 13) Cyclists (N = 22) P-value: time effect; interaction effect
Granulocyte phagocytosis (MFI)
Pre-exercise 7018 ± 770 7092 ± 675 <0.001
Post-3day-exercise 9901 ± 620 9393 ± 676 0.942
1 h-Post-exercise 9839 ± 550 9897 ± 630
14 h-Post-exercise 4940 ± 718 5302 ± 453
38 h-Post-exercise 5866 ± 681 5595 ± 569
Monocyte phagocytosis (MFI)
Pre-exercise 5218 ± 685 4769 ± 436 <0.001
Post-3day-exercise 8343 ± 454 7806 ± 652 0.897
1 h-Post-exercise 8242 ± 483 8256 ± 566
14 h-Post-exercise 3403 ± 502 3710 ± 408
38 h-Post-exercise 4446 ± 663 4381 ± 535
Granulocyte oxidative burst activity (MFI)
Pre-exercise 8.57 ± 0.32 8.85 ± 0.29 <0.001
Post-3day-exercise 10.4 ± 0.38 10.3 ± 0.49
1 h-Post-exercise 9.44 ± 0.93 9.96 ± 0.62
14 h-Post-exercise 8.27 ± 0.44 8.78 ± 0.57
38 h-Post-exercise 7.10 ± 1.07 8.08 ± 0.77
Monocyte oxidative burst activity (MFI)
Pre-exercise 5.84 ± 0.19 5.52 ± 0.20 <0.001
Post-3day-exercise 7.18 ± 0.29 6.59 ± 0.32 <0.001
1 h-Post-exercise 6.45 ± 0.34 6.75 ± 0.36
14 h-Post-exercise 5.09 ± 0.17 4.94 ± 0.22
38 h-Post-exercise 4.19 ± 0.57 4.64 ± 0.46not shown). Scores for URTI severity, symptoms, and function abil-
ity during the 12-week logging period did not differ between the
runners and cyclists (Table 3).4. Discussion
The 3-day period of intensified exercise was associated with
significantly more muscle damage and soreness, and systemic
inflammation, in the runners compared to the cyclists, despite sim-
ilar exercise workload volumes (2.5 h/day). Post-exercise down-
turns in granulocyte and monocyte phagocytosis and oxidative
burst activity, and 12-week URTI symptomatology did not differ
between these athletic groups.
This contrast in muscle damage, DOMS, and systemic inflamma-
tion during recovery from intensive running (i.e., more eccentric)
versus cycling (i.e., more concentric) confirms and extends findings
from several other studies. Bruunsgaard et al. (1997) were the first
to show higher CK and IL-6 after 30 min of eccentric versus concen-
tric cycling, hypothesizing that this finding was probably related to
muscle damage and ensuing inflammatory reactions in the skeletal
muscle. However, in a follow-up study utilizing 60 min of eccentric
lower limb exercise, IL-6 increases were modest compared to large
CK increases, suggesting that muscle damage was not a major
stimulus to IL-6 production, especially when compared to the large
IL-6 increases observed during high intensity, long duration cycling
(Pedersen, 2012; Toft et al., 2002). The 3-day functional overreach-
ing model utilized in this study showed that under demanding
exercise workloads, 7.5 h of running compared to cycling is associ-
ated with significantly more muscle damage (CK was 133% and
MYO 404% higher post-3 day exercise), muscle soreness (87% high-
er), and systemic inflammation (CRP 87%, IL-6 256%, IL 8 61%, IL-10
32%, and MCP 29% higher).
Other studies provide variable support for the linkage between
muscle damage and systemic inflammation, and part of the prob-
lem is that many exercise protocols did not combine the duration
and intensity needed to induce sizeable increases in outcome mea-
sures (Nieman et al., 2005; Paulsen et al., 2012; Peake et al.,
2005a,b; Sugama et al., 2012; Suzuki et al., 2006). Ultramarathonrunning generates significant muscle damage and soreness, and
data collected from 155 athletes competing in the 160-km WSER
supported a strong relationship between CK and various cytokines
including IL-6 (r = 0.49, P < 0.001) and GCSF (r = 0.42, P < 0.001)
(Nieman, 2009; Nieman et al., 2005). DOMS was higher the day
after the WSER (7.1 ± 0.3) and was significantly correlated with
CK and pre-to-post changes in IL-6, GCSF, IL-10, and MCP (Nieman
et al., 2005). Sugama et al. (2012) and Suzuki et al. (2006) also re-
ported concomitant increases in muscle damage and a variety of
cytokines during recovery from long endurance, competitive race
events.
Welc and Clanton (2013) proposed that IL-6 gene regulation in
muscle is responsive to a variety of internal and external stress sig-
nals. Although IL-6 can be released from the muscle that has not
been significantly damaged from exercise (Fischer, 2006), the high-
est post-exercise levels reported in the literature are in runners fol-
lowing marathon and ultra-marathon type events that induce
muscle damage and DOMS (Nieman, 2001, 2009; Suzuki et al.,
2006). In this study, 7.5 h of running compared to cycling at the
same workload intensity over a 3-day period caused more muscle
damage and 2.56-fold greater plasma IL-6 concentrations. IL-6 is
not only released by the working muscle but targets this tissue,
assisting in regulation of muscle satellite cells, energy metabolism,
and regeneration (Muñoz-Cánoves et al., 2013). In regenerating
muscle, IL-6 is produced by infiltrating neutrophils and macro-
phages, fibro-adipogenic progenitors, and satellite cells (Joe et al.,
2010; Muñoz-Cánoves et al., 2013). Thus there are multiple poten-
tial underlying mechanisms linking exercise-induced muscle dam-
age with IL-6 and other cytokines.
Limited evidence suggests that overreaching is associated with
increased incidence of URTI and immune dysfunction, including
decreases in neutrophil and monocyte oxidative burst activity, nat-
ural killer cell activity, and salivary IgA concentrations, and im-
paired exercise-induced CD8+ T lymphocyte redistribution
(Henson et al., 2008; Lancaster et al., 2004; Meeusen et al., 2013;
Morgado et al., 2012; Reid et al., 2004; Robson et al., 1999; Witard
et al., 2012). The data from this study support previous findings,
with the 3-day period of exercise associated with significant down-
turns in GR-PHAG (;27%), MO-PHAG (;28%), GR-OBA (;12%), and
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Fig. 1. A through E Serum C-reactive protein (A), plasma IL-6 (B), plasma IL-8 (C),
plasma IL-10 (D), and plasma MCP (E) in runners and cyclists before and during 38 h
of recovery from a 3-day period of intensified exercise (mean ± SE). ⁄P < 0.0125,
between group contrast with pre-exercise.
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Fig. 2. Serum myoglobin (A) and serum creatine kinase (B) in runners and cyclists
before and during 38 h of recovery from a 3-day period of intensified exercise
(mean ± SE). ⁄P < 0.0125, between group contrast with pre-exercise.
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Fig. 3. Delayed onset of muscle soreness (DOMS) in runners and cyclists before and
during 38 h of recovery from a 3-day period of intensified exercise (mean ± SE).
⁄P < 0.0125, between group contrast with pre-exercise.MO-OBA (;21%) by 14- and 38 h-recovery. Downturns in these
measures of innate immune function were modest, however, and
did not differ between runners and cyclists, despite disparities in
muscle damage and systemic inflammation. These results are sim-
ilar to a previous randomized, crossover study with 10 triathletes
who experienced higher IL-6 after running compared to cycling
2.5 h at 75% VO2max, but similar responses in GR-PHAG, MO-PHAG,
GR-OBA, MO-OBA, natural killer cell activity, mitogen-induced
lymphocyte proliferation, and stress hormones (Henson et al.,
1999; Nieman et al., 1998a,b).
In the current study, no group differences were measured for
12-week URTI severity and symptom scores, and this result is con-
sistent with the lack of group differences for innate immune func-
tion (both pre- and post-exercise). Thus despite higher muscle
damage, muscle soreness, and inflammation in the runners com-
pared to cyclists after the 3-day period of intensified exercise, there
is no indication that this leads to unusual disturbances in innate
immune function and or higher 12-week scores for URTI symptom-
atology. A limitation in the current study is that a sedentary con-
trol group was not utilized to allow comparisons in URTI
symptoms scores with the athletic groups.
Table 3
Upper respiratory tract infection (URTI) data (mean ± SE).
Variable Runners (N = 13) Cyclists (N = 22) P-value: interaction effect
URTI measures (12-weeks)
URTI severity score 18.3 ± 5.6 16.6 ± 4.0 0.803
URTI symptom score 33.4 ± 12.6 24.7 ± 5.8 0.477
URTI function ability score 15.0 ± 6.4 18.3 ± 6.0 0.725In summary, short-term functional overreaching (3 days, 2.5 h/
day, inserted at week 5 during the 12-week study period) was
associated with significantly more muscle damage, DOMS, and
systemic inflammation in runners than cyclists. The runners
and cyclists engaged in comparable volumes of training over the
12-week study period, and experienced similar scores for URTI
symptomatology and 3-day post-exercise downturns in innate im-
mune function. Thus runners compared to cyclists may experience
more discomfort during short-term functional overreaching, but
without unusual compromises in innate immune function and
URTI symptom scores. To limit muscle damage, soreness, and
inflammation, runners are encouraged to emphasize periodization
in their training schedules, the inclusion of other training modali-
ties, and control of workload volumes to lower levels than can be
tolerated by cyclists.References
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